Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164.6 USD | -1.12% | +2.03% | +6.19% |
05-17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
05-17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
Official Publications
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
Annual ESG Report | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
Dividends | CO |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Official Publications